Clover Health Investments, Corp.
CLOV
$2.26
-$0.59-20.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 94.23% | -141.31% | -223.58% | 138.64% | 72.80% |
| Total Depreciation and Amortization | 35.47% | 1.47% | 2.73% | 3.77% | -52.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 365.70% | -136.20% | 6.54% | 27.81% | 122.16% |
| Change in Net Operating Assets | 22.41% | -273.15% | 180.04% | -54.55% | 125.31% |
| Cash from Operations | 81.02% | -271.71% | 11.68% | 72.57% | 110.05% |
| Capital Expenditure | 41.27% | 21.05% | -0.50% | 10.79% | -268.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 910.94% | 90.42% | -319.32% | -44.43% | -88.45% |
| Cash from Investing | 720.57% | 88.14% | -344.95% | -46.06% | -89.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.37% | 199.55% | 856.52% | -- | -- |
| Repurchase of Common Stock | -369.94% | -39.17% | -51.83% | 4.20% | -306.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -416.87% | -31.61% | -46.04% | 4.88% | -306.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.14% | -381.49% | -28.66% | 46.46% | 118.12% |